Biogen (BIIB), AbbVie (ABBV) Receive Health Canada Approve for Once-Monthly Zinbryata
December 9, 2016 8:15 AM
Health Canada has approved ZINBRYTA™ (daclizumab beta), a new once-monthly, self administered, subcutaneous treatment for adult patients with active relapsing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
